WeVote
Log In

Bill

Bill

SB 1582

Establishes a University of Missouri governance board for reporting on research related to rare pediatric diseases

2026 Regular Session Introduced by Kurtis Gregory

SB 1582 establishes a University of Missouri board to oversee and report on rare pediatric disease research activities.

0
WeVote Research Nonpartisan
Bill Summary · SB 1582

Legislative bill overview

SB 1582 creates a University of Missouri governance board tasked with reporting on research activities related to rare pediatric diseases. The bill establishes oversight and documentation requirements for how the university conducts and communicates research in this specialized medical field.

Why is this important

Rare pediatric diseases affect relatively small patient populations, making them less financially attractive for pharmaceutical development despite significant health impacts on affected children and families. Establishing dedicated reporting mechanisms can increase transparency, coordinate research efforts, and potentially attract more attention and resources to understudied conditions that currently lack adequate treatment options.

Potential points of contention

  • Regulatory burden: Creating new board structures and reporting requirements may impose administrative costs on the university without corresponding funding increases
  • Scope ambiguity: The bill's language regarding which diseases qualify as "rare pediatric" and what constitutes reportable "research" may need clarification to avoid disputes over compliance
  • Governance clarity: It remains unclear whether this board has advisory-only status or actual decision-making authority over research direction, which affects its practical impact on university operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.